Test Price
2,800 AED✅ Home Collection Available
VLDLR Gene: Cerebellar Hypoplasia & Mental Retardation with or Without Quadrupedal Locomotion – Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين VLDLR للكشف عن نقص تنسج المخيخ والتخلف العقلي مع أو بدون الحركة الرباعية في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary & UAE Trust Guarantee
ملخص تنفيذي: يقدم اختبار تسلسل الجين VLDLR عبر تقنية الجيل التالي (NGS) تشخيصًا دقيقًا للطفرة المسببة لنقص تنسج المخيخ والتخلف العقلي والحركة الرباعية، بنسبة دقة تبلغ 99.9%، ويتم وفق معايير الآيزو 9001:2015 وتحت إشراف هيئة الصحة بدبي، مع توفير خدمة السحب المنزلي المعتمد واستشارة ما بعد النتيجة عبر الهاتف.
- ✔ Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- ✔ Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection & VIP Mobile Phlebotomy, 8 AM – 11 PM.
- ✔ Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation with DHA-licensed genetic counselling.
- ✔ Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731. All major UAE insurers accepted.
Test Overview
The VLDLR gene NGS test identifies pathogenic variants causing autosomal recessive cerebellar hypoplasia, intellectual disability, and quadrupedal gait. This advanced sequencing technology ensures comprehensive coverage of all coding regions, splice sites, and regulatory elements, enabling early diagnosis and family planning for UAE patients.
يفحص تحليل الجين VLDLR كامل المناطق المشفّرة والمواقع الحدودية لتحديد الطفرات المسببة للمرض، مما يضمن تغطية شاملة ودقة تشخيصية عالية. يُستخدم في الإمارات لتوجيه التدخل المبكر وتقديم الاستشارة الوراثية.
| Feature | Our Test – Premium NGS | Closest Alternative – Single-Gene Sanger |
|---|---|---|
| Diagnostic Precision | 99.9% (full gene, deep coverage) | ~95% (limited to known hotspots) |
| Methodology | NGS (Next Generation Sequencing) with CNV analysis | Sanger sequencing, exon by exon |
| Turnaround Time | 3 to 4 weeks | 4 to 6 weeks |
| Sample Options | Blood, FTA card, extracted DNA | Blood or DNA, limited card acceptance |
Physician Insight & Safety Protocol
“This genetic test provides a molecular window into a complex neurodevelopmental phenotype. It must be interpreted in the context of a comprehensive neurological and developmental evaluation. A negative result does not rule out other genetic causes, while a positive finding demands correlation with clinical presentation and cascade family testing under the guidance of a medical geneticist.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011, Consultant Neurologist & Clinical Geneticist
⚠️ Medication Warning:
Do not discontinue any prescribed medication without first consulting your treating physician. The results of this genetic test are intended to inform clinical decision-making, not replace ongoing therapeutic management.
Exclusion Criteria & Emergency Red Flags
- Exclusion Criteria: Recent blood transfusion (<2 weeks), heparinized sample (use EDTA only), dried blood spot card improperly stored; test not recommended for prenatal diagnosis unless amniocentesis is clinically indicated and discussed with a fetal medicine specialist.
- Emergency Red Flags: If the patient experiences new-onset seizures, acute neurological deterioration, severe feeding difficulties, or loss of previously acquired motor skills, seek immediate medical evaluation at the nearest DHA/MOHAP-licensed emergency department. Do not wait for genetic test results.
Patient FAQ & Clinical Guidance
Q1: What is the VLDLR gene test, and why is it performed in the UAE?
Snippet Answer: The VLDLR gene test uses next-generation sequencing to detect pathogenic variants causing autosomal recessive cerebellar hypoplasia and intellectual disability, guiding clinical diagnosis and genetic counselling for UAE families.
جواب مختصر: يهدف هذا التحليل إلى كشف الطفرات في جين VLDLR المرتبطة بنقص تنسج المخيخ والتخلف العقلي والحركة الرباعية، ويُستخدم لتأكيد التشخيص وتوجيه الاستشارة الوراثية.
Q2: How is the sample collected, and how long until I receive the results?
Snippet Answer: A certified phlebotomist collects a blood sample, one drop of blood on an FTA card, or extracted DNA at your home; results are issued within 3 to 4 weeks, with optional expedited reports.
جواب مختصر: يتم سحب العينة منزليًا عبر ممرض معتمد باستخدام عينة دم أو بطاقة FTA، وتصدر النتائج خلال ٣ إلى ٤ أسابيع مع إمكانية تسريع التقرير.
Q3: Is this genetic test covered by UAE health insurance?
Snippet Answer: We verify direct billing eligibility with major UAE insurers via WhatsApp +971 54 548 8731, offering a seamless payment experience before the; most policies cover diagnostically necessary genetic testing.
جواب مختصر: نتحقق من تغطية التأمين مباشرة عبر واتساب +971 54 548 8731، وتقبل معظم خطط التأمين في الإمارات الفحوصات الجينية عند وجود مبرر طبي.
This diagnostic service is provided under DHA Facility License 9834453. All procedures comply with UAE Federal Decree-Law No. 41 of 2024 (Article 87), CDS Law 2026 (Minors Protection provisions), and UAE Personal Data Protection Law (PDPL). Genetic counselling session is mandatory prior to testing to draw a pedigree chart of affected family members.
Methodology: NGS (Next Generation Sequencing) – LC‑MS/MS validation for any associated biochemical markers. ICD‑10‑CM 2026: G11.8, F78.9, Z15.09 | LOINC: 94133‑1 (loinc.org/94133-1).
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians